CONMED stock gains 3.85 percent to EUR 40.50 on Lang & Schwarz
Published on 10/01/2026 at 01:33 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CONMED stock (ISIN US2074101013) was last at EUR 40.50 on Lang & Schwarz on September 22, 2026 at 8:57 p.m. CEST, up 3.85 percent versus the EUR 39.00 prior close. The medical-device maker's Q2 results delivered a sharper earnings comparison than its near-flat sales growth.
Q2 earnings beat consensus
According to MarketBeat, CONMED reported adjusted EPS of USD 1.38 for Q2 2026, above the USD 1.11 consensus, while revenue reached USD 343.49 million versus USD 337.60 million expected. Revenue increased 0.30 percent from the prior-year quarter, but the earnings beat was the stronger operating signal.
The filing summary published by StockTitan shows GAAP diluted EPS of USD 0.77 and net income of USD 23.1 million for Q2 2026. Gross margin reached 57.50 percent, while first-half revenue totaled USD 660.5 million.
Orthopedics offsets portfolio exit
CONMED's Q2 2026 operating mix was uneven. Orthopedic surgery sales grew 8.20 percent, while gastroenterology revenue fell to USD 4.7 million from USD 25.3 million as the company exited parts of that product portfolio, according to StockTitan.
Management's fiscal 2026 adjusted EPS guidance stood at USD 4.48-4.60 in the September 2026 market coverage. That range gives the earnings beat a forward benchmark, while the declining gastroenterology contribution remains a measurable counter-factor.
Analyst target stays below quote
MarketBeat reported a consensus Reduce rating from eight analysts, with six Holds and two Sells, and an average 12-month target of USD 41.40. The target is USD 4.77 below the last reported NYSE price of USD 46.17 on September 22, 2026, a gap of 10.33 percent.
EUR 40.50 was the latest quote
CONMED stock was last at EUR 40.50 on Lang & Schwarz on September 22, 2026 at 8:57 p.m. CEST, versus the EUR 39.00 prior close of September 21, 2026. Finance data put CONMED's market capitalization at USD 1.4 billion as of September 30, 2026, with a 52-week range of USD 31.44 to USD 53.66.
CONMED stock facts
- Company: CONMED Corporation
- ISIN: US2074101013
- Ticker: CNMD
- Primary exchange: NYSE
- Price Lang & Schwarz as of September 22, 2026, 8:57 p.m. CEST: EUR 40.50
- Change versus prior close: plus 3.85 percent
- Prior close Lang & Schwarz September 21, 2026: EUR 39.00
- Market capitalization: USD 1.4 billion as of September 30, 2026
- 52-week range: USD 31.44-53.66 as of September 30, 2026
- Sector / Industry: Healthcare / Medical Devices
